Natural history and disease burden of biliary atresia in the United States: A systematic literature review
Journal of Pediatric Gastroenterology and Nutrition · 18.11.2026
DOI: 10.1002/jpn3.70686 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 18.11.2026. Verfasst von Tebyan A. Rabbani und 6 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ipsen Biopharmaceuticals.
Abstract (Originalsprache)
Objective
Biliary atresia (BA) is a rare and potentially fatal cholangiopathy affecting infants. The primary treatment approach for BA is Kasai hepatoportoenterostomy (KP); however, even with KP, many patients still require liver transplantation (LT). The objective of this systematic literature review (SLR) was to describe epidemiology, natural history, and native liver survival (NLS), as well as the humanistic and economic burden, in patients with BA in the United States (US).
Methods
Embase and MEDLINE searches were performed; US‐based, English‐language publications from 2014 to 2024 were included. Additional searches were conducted for non‐peer‐reviewed publications, including congress abstracts. The SLR was conducted per Preferred Reporting Items for Systematic reviews and Meta‐Analyses guidelines.
Results
Across epidemiology, natural history, and NLS, 38/3485 records were included; for the humanistic and economic burden outcomes, 16/1471 records were included. Sample sizes ranged from 10 to 4306 patients, and BA prevalence was 6.5–6.8 per 100,000 live births. Complications of BA included various hepatic, cardiovascular, and renal abnormalities, among others. Post‐transplant graft survival rates ranged from 86.0%–96.0% and 79.0%–97.0% at 1 and 5 years post‐LT, respectively. BA was also associated with high healthcare resource utilization (HCRU) and disease costs. Overall, sample heterogeneity and study design differences made comparisons across studies difficult.
Conclusions
Although there are limited data on BA outcomes in the US, and the published BA studies are heterogeneous, this SLR reveals a substantial burden due to BA‐related care and complications. Additionally, data on HCRU and costs highlight the unmet need for additional management and research in BA.
Förderung
- Ipsen Biopharmaceuticals
Zitieren
APA
Rabbani, T. A., Los, A., Lee, S., Navickas, C., Khankhel, Z., Shamseddine, N., & Mack, C. L. (2026). Natural history and disease burden of biliary atresia in the United States: A systematic literature review. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70686
Vancouver
Rabbani TA, Los A, Lee S, Navickas C, Khankhel Z, Shamseddine N, et al. Natural history and disease burden of biliary atresia in the United States: A systematic literature review. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70686
BibTeX
@article{Rabbani2026,
author = {Rabbani, Tebyan A. and Los, Agata and Lee, Sonia and Navickas, Colin and Khankhel, Zarmina and Shamseddine, Nisreen and Mack, Cara L.},
title = {Natural history and disease burden of biliary atresia in the United States: A systematic literature review},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70686}
}
EUVIMED